PP2A has been characterized as a tumor suppressor gene and activation of PP2A inhibits tumor growth (Sangodkar et al., 2016, 2017), while inhibition of PP4 and PP6 induces cancer cell death and sensitizes to radiation therapy (Shen et al., 2011; Theobald et al., 2013). The gene discussed is PPP6C; the disease is neoplasm.